Let’s talk. Our first meeting is free of charge and free of any obligations.
Identifying the best quality antibodies in the market that meet your specific research requirements should be straightforward and not be a monumental task. We understand all too well that searching for the right one can lead to many frustrations. You are here because you want to spend your valuable time in the lab generating scientific data, instead of contemplating which brand to chose and still running the risk that the antibody doesn’t perform as promised.
In the current market there are many antibodies against the same target protein on offer, often duplicated through rebranding, and often accompanied with false or unsubstantiated claims. With our experience and expertise spanning over decades, we have identified all the obvious and not-so-obvious pitfalls that come with shopping for commercial antibodies sold for R&D purposes. This accumulated knowledge has enabled us to introduce an objective tool that identifies the products with the highest grade of specifications.
Our proprietary Aeonian Rating® sets a new quality standard independent of the number of applications the antibody is claimed fit for. Instead, the quality of the data is a determining factor. We will use this tool to find what you need quickly and effectively. Your projects will be kept confidential, and we are always prepared to sign a non-disclosure agreement. Let’s talk. Our first chat is purely for orientation/ introduction and without any obligations. You will be directly put in contact with our director and founder Jan Voskuil. Let’s increase your time in the lab, instead of spending hours browsing vendors’ catalogues.
“Levels Diagnostics has collaborated with Aeonian Biotech in the search for suitable antibodies and antigens for biomarker candidates currently being developed by Levels Diagnostics.
The advice provided by CEO Jan Voskuil was very useful and allowed Levels Diagnostics to quickly progress their development.
The years of experience Jan provides directly translate to actionable results and changed courses for some of the biomarker candidates. Levels Diagnostics will continue to contribute to improving and testing the Aeonian Rating® and is looking forward to further strengthening the collaboration with Aeonian Biotech.”
Coen Breedveld, CEO of Levels Diagnostics, 22nd November 2022
Director & Founder Aeonian Biotech